BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32888404)

  • 1. Conformational States of the Cytoprotective Protein Bcl-xL.
    Ryzhov P; Tian Y; Yao Y; Bobkov AA; Im W; Marassi FM
    Biophys J; 2020 Oct; 119(7):1324-1334. PubMed ID: 32888404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the membrane-inserted C-terminus of cytoprotective BCL-XL.
    Yao Y; Nisan D; Fujimoto LM; Antignani A; Barnes A; Tjandra N; Youle RJ; Marassi FM
    Protein Expr Purif; 2016 Jun; 122():56-63. PubMed ID: 26923059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation of BCL-XL upon Membrane Integration.
    Yao Y; Fujimoto LM; Hirshman N; Bobkov AA; Antignani A; Youle RJ; Marassi FM
    J Mol Biol; 2015 Jul; 427(13):2262-70. PubMed ID: 25731750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Cardiolipin on the Conformational Dynamics of Membrane-Anchored Bcl-xL.
    Tyagi V; Vasquez-Montes V; Freites JA; Kyrychenko A; Tobias DJ; Ladokhin AS
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of Bcl-xL in water and membrane: molecular simulations.
    Maity A; Yadav S; Verma CS; Ghosh Dastidar S
    PLoS One; 2013; 8(10):e76837. PubMed ID: 24116174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Sampling of Intrinsic Structural Heterogeneity of the BH3-Only Protein Binding Interface of Bcl-xL.
    Liu X; Jia Z; Chen J
    J Phys Chem B; 2017 Oct; 121(39):9160-9168. PubMed ID: 28903561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of the BH3-Only Protein Binding Interface of Bcl-xL.
    Liu X; Beugelsdijk A; Chen J
    Biophys J; 2015 Sep; 109(5):1049-57. PubMed ID: 26331262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid destabilization of the solution conformation of Bcl-xL does not drive its pH-dependent insertion into membranes.
    Thuduppathy GR; Hill RB
    Protein Sci; 2006 Feb; 15(2):248-57. PubMed ID: 16385002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the interaction of pro-apoptotic tBID with pro-survival BCL-XL.
    Yao Y; Bobkov AA; Plesniak LA; Marassi FM
    Biochemistry; 2009 Sep; 48(36):8704-11. PubMed ID: 19670908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.
    Muchmore SW; Sattler M; Liang H; Meadows RP; Harlan JE; Yoon HS; Nettesheim D; Chang BS; Thompson CB; Wong SL; Ng SL; Fesik SW
    Nature; 1996 May; 381(6580):335-41. PubMed ID: 8692274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Deamidation on the Structure and Function of Antiapoptotic Bcl-x
    Tanriver G; Monard G; Catak S
    J Chem Inf Model; 2022 Jan; 62(1):102-115. PubMed ID: 34942070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis.
    Sattler M; Liang H; Nettesheim D; Meadows RP; Harlan JE; Eberstadt M; Yoon HS; Shuker SB; Chang BS; Minn AJ; Thompson CB; Fesik SW
    Science; 1997 Feb; 275(5302):983-6. PubMed ID: 9020082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-modulation of membrane insertion and refolding of the apoptotic inhibitor Bcl-xL.
    Vasquez-Montes V; Vargas-Uribe M; Pandey NK; Rodnin MV; Langen R; Ladokhin AS
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):691-700. PubMed ID: 31004798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the interaction between DJ-1 and Bcl-X
    Lee MK; Lee MS; Bae DW; Lee DH; Cha SS; Chi SW
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1067-1073. PubMed ID: 29175327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional similarity between the bacterial type III secretion system needle protein PrgI and the eukaryotic apoptosis Bcl-2 proteins.
    Shortridge MD; Powers R
    PLoS One; 2009 Oct; 4(10):e7442. PubMed ID: 19823588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational Switching in Bcl-xL: Enabling Non-Canonic Inhibition of Apoptosis Involves Multiple Intermediates and Lipid Interactions.
    Vasquez-Montes V; Kyrychenko A; Vargas-Uribe M; Rodnin MV; Ladokhin AS
    Cells; 2020 Feb; 9(3):. PubMed ID: 32111007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between Bcl-xl and its inhibitors: Insights into ligand design from molecular dynamics simulation.
    Priya P; Maity A; Majumdar S; Ghosh Dastidar S
    J Mol Graph Model; 2015 Jun; 59():1-13. PubMed ID: 25817992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Conformational Space of Bcl-2 Protein Variants: Dynamic Contributions of the Flexible Loop Domain and Transmembrane Region.
    Caro-Gómez LA; Rosas-Trigueros JL; Mixcoha E; Vique-Sánchez JL; Gasperin-Sánchez H; Benítez-Cardoza CG; Zamorano-Carillo A
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31671865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles.
    Yao H; Mi S; Gong W; Lin J; Xu N; Perrett S; Xia B; Wang J; Feng Y
    Biochemistry; 2013 Sep; 52(37):6324-34. PubMed ID: 23977882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1.
    Feng W; Huang S; Wu H; Zhang M
    J Mol Biol; 2007 Sep; 372(1):223-35. PubMed ID: 17659302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.